Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Positive, HER2-Negative Advanced Breast Cancer

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages e182262

出版商

American Medical Association (AMA)

发表日期

2018-06-04

DOI

10.1001/jamaoncol.2018.2262

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started